Mobile

A phase II, observer-blind, randomized trial to evaluate the safety and immunogenicity of a two-dose schedule of the A/California/7/2009 (H1N1)v-like candidate vaccine manufactured in Dresden adjuvant...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-014449-96

A phase II, observer-blind, randomized trial to evaluate the safety and immunogenicity of a two-dose schedule of the A/California/7/2009 (H1N1)v-like candidate vaccine manufactured in Dresden adjuvanted with AS03A in adults aged 18 to 60 years

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the humoral response of two doses of the H1N1 vaccine (A/California/7/2009 (H1N1)v-like) containing an antigen-sparing dose of HA with AS03A in terms of haemagglutination inhibition (HI) against the vaccine-homologous virus at 14 days after the second dose of H1N1 vaccine in adults 18 to 60 years of age.

Critère d'inclusion

  • Immunization against A/California/7/2009 (H1N1)v-like influenza in male and female subjects aged 18 years and above

Liens